Together, these data suggest that at this early stage of HE specification, a small subset of CD31+CD144+ endothelial cells has upregulated RUNX1b expression but this has not yet led to significant changes in their transcriptional landscape. The gene discussed is PECAM1; the disease is hereditary elliptocytosis.